Stem Cell Innovations Report issue

For profit
Founded: Houston TX United States (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Other Trials (1)

Key: Stem Cell Innovations (0) Acquired (1)

interferon alfa-n3 (Alferon-N) (2 trials)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 2
  • # of Trial APIs: 1